Harrison & Co Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Harrison & Co Wealth Management's LLY Position: Q4 2022 in Review
Harrison & Co Wealth Management reduced its Eli Lilly (LLY) stake by 13% in Q4 2022, selling an estimated $169K and leaving 3,333 shares worth $1.22M. The position accounts for 1.18% of the portfolio, ranked #22.
Harrison & Co Wealth Management first reported a position in LLY in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.44M in Q2 2022. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Harrison & Co Wealth Management held 3,333 shares of Eli Lilly worth $1.22M as of Q4 2022.
- Harrison & Co Wealth Management sold 477 Eli Lilly shares in Q4 2022, an estimated $169K.
- Eli Lilly made up 1.18% of Harrison & Co Wealth Management's portfolio in Q4 2022, its #22 holding.
- Harrison & Co Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 5 quarters since.
- Harrison & Co Wealth Management's Eli Lilly position peaked at $1.44M in Q2 2022.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Harrison & Co Wealth Management's 13F filing for Q4 2022, filed 17 Jan 2023.